Cardiovascular disease in metabolic-associated fatty liver disease

被引：0
|
作者：
Adams, Leon A. [1 ,2 ,3 ]
机构：
[1] Univ Western Australia, Med Sch, Nedlands, WA, Australia
[2] Sir Charles Gairdner Hosp, Dept Hepatol, Nedlands, WA, Australia
[3] Univ Western Australia, Med Sch, M503,QEII Med Campus,Verdun St, Nedlands, WA 6009, Australia
来源：
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY | 2023年 / 30卷 / 02期
关键词：
cardiovascular risk; metabolic-associated fatty liver disease; nonalcoholic fatty liver disease; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; HEART-DISEASE; INSULIN-RESISTANCE; RISK; DYSLIPIDEMIA; DYSFUNCTION; MEN;
D O I：
10.1097/MED.0000000000000803
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Purpose of reviewFatty liver disease is increasingly common worldwide and is associated with an increased risk of cardiovascular disease (CVD).Recent findingsThis review describes the cardiovascular outcomes, clinical assessment and management as well as the impact of emerging drug treatment on CVD risk.Patients with fatty liver require CVD risk assessment including consideration of statin therapy. Emerging therapeutic drugs for fatty liver may have both adverse and beneficial effects on CVD risk.
引用
收藏
页码：81 / 86
页数：6
相关论文
共 50 条
  • [1] Metabolic-associated fatty liver disease and the risk of cardiovascular disease
    Zhang, Pengwei
    Dong, Xianhui
    Zhang, Wei
    Wang, Shiyin
    Chen, Chen
    Tang, Jiake
    You, Yao
    Hu, Siqi
    Zhang, Shenghui
    Wang, Chunyi
    Wen, Wen
    Zhou, Mengyun
    Tan, Tao
    Qi, Guanming
    Li, Li
    Wang, Mingwei
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (01)
  • [2] Metabolic-associated Fatty Liver Disease
    Zheng, Ming-Hua
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (06) : 793 - 794
  • [3] Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
    Olufunto O. Badmus
    Terry D. Hinds
    David E. Stec
    [J]. Current Hypertension Reports, 2023, 25 : 151 - 162
  • [4] Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
    Badmus, Olufunto O.
    Hinds, Terry D.
    Stec, David E.
    [J]. CURRENT HYPERTENSION REPORTS, 2023, 25 (08) : 151 - 162
  • [5] Metabolic-Associated Fatty Liver Disease and Sarcopenia
    Bali, Triada
    Chrysavgis, Lampros
    Cholongitas, Evangelos
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03) : 497 - 508
  • [6] Pathobiology of Metabolic-Associated Fatty Liver Disease
    Fouda, Sherouk
    Jeeyavudeen, Mohammed Sadiq
    Pappachan, Joseph M.
    Jayanthi, Venkataraman
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03) : 405 - 416
  • [7] Alcohol and Metabolic-associated Fatty Liver Disease
    Sun, Fu-Rong
    Wang, Bing-Yuan
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (05) : 719 - 730
  • [8] Lean Metabolic-Associated Fatty Liver Disease
    Gofton, Cameron
    Clark-Dickson, McCawley
    George, Jacob
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03) : 431 - 444
  • [9] Metabolic-associated fatty liver disease (MAFLD) in coeliac disease
    Rispo, Antonio
    Imperatore, Nicola
    Guarino, Maria
    Tortora, Raffaella
    Alisi, Anna
    Cossiga, Valentina
    Testa, Anna
    Ricciolino, Simona
    Fiorentino, Andrea
    Morisco, Filomena
    [J]. LIVER INTERNATIONAL, 2021, 41 (04) : 788 - 798
  • [10] Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome
    Sinn, Dong Hyun
    Kang, Danbee
    Choi, Sung Chul
    Hong, Yun Soo
    Zhao, Di
    Guallar, Eliseo
    Park, Yewan
    Cho, Juhee
    Gwak, Geum-Youn
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1873 - +
12345